Natera shared a post on LinkedIn:
“Join Prakash Peddi, MD for a focused presentation on real-world evidence (RWE) and patient case studies demonstrating how to translate positive ctDNA / MRD test results into actionable clinical management strategies for breast cancer patients.
Key takeaways include:
- Post-treatment risk stratification
- Clinical decision-making
- Navigating positive Signatera findings in everyday practice
Register.”
You can also read: Natera’s Multi-Cancer Early Detection Assay Receives FDA Breakthrough Designation, Targeting Screening Gaps
